RVTY raises margin guidance as AI-driven demand lifts growth
AI-driven demand is accelerating growth in high-content screening and software, while a tuck-in acquisition strengthens the reagents portfolio. Diagnostics and reproductive health segments remain robust, and margin guidance has been raised on strong execution.